AERIE PHARMACEUTICALS INC Business Finance Contracts & Agreements
35 Contracts & Agreements
- Credit Agreements (1 contract)
- Exchange Agreements (1)
- Guaranty Agreements (2)
- Indenture Agreements (2)
- Investor Rights Agreements (2)
- Loan Agreements (2)
- Note Agreements (2)
- Registration Rights Agreements (1)
- Security Agreements (1)
- Stock Agreements (18)
- Underwriting Agreements (3)
- First Supplemental Indenture, dated as of November 21, 2022, by and between Aerie Pharmaceuticals, Inc. and Wilmington Trust, National Association (Filed With SEC on November 21, 2022)
- Form of Aerie Pharmaceuticals, Inc. Inducement Award Plan Restricted Stock Agreement (Filed With SEC on February 25, 2022)
- Form of Aerie Pharmaceuticals, Inc. Inducement Award Plan Restricted Stock Agreement (Raj Kannan) (Filed With SEC on February 25, 2022)
- Form of Aerie Pharmaceuticals, Inc. Inducement Award Plan Nonqualified Stock Option Agreement (Raj Kannan) (Filed With SEC on February 25, 2022)
- Form of Aerie Pharmaceuticals, Inc. Restricted Stock Unit Award Agreement (Filed With SEC on February 24, 2020)
- Indenture, dated as of September 9, 2019, by and between Aerie Pharmaceuticals, Inc. and Wilmington Trust, National Association, as trustee (Filed With SEC on September 10, 2019)
- Amended and Restated Credit Agreement, dated as of May 2, 2019, by and among Aerie Pharmaceuticals, Inc., Aerie Distribution, Inc., the other Loan Parties (as defined therein)... (Filed With SEC on May 3, 2019)
- Amended and Restated Guaranty and Security Agreement, dated as of May 2, 2019, by and among Aerie Pharmaceuticals, Inc., the other Grantors and Guarantors (each as defined... (Filed With SEC on May 3, 2019)
- First Amendment to Credit Agreement, dated as of August 7, 2018, by and among Aerie Pharmaceuticals, Inc., the guarantors party thereto, the lenders party thereto, and Deerfield... (Filed With SEC on August 9, 2018)
- Guaranty and Security Agreement, dated as of July 23, 2018, by and among Aerie Pharmaceuticals, Inc., the other Grantors and Guarantors (each as defined therein) party thereto... (Filed With SEC on July 23, 2018)
- Credit Agreement, dated as of July 23, 2018, by and among Aerie Pharmaceuticals, Inc., Aerie Distribution, Inc., the other Loan Parties (as defined therein) party thereto from... (Filed With SEC on July 23, 2018)
- Registration Rights Agreement, dated as of July 23, 2018, by and among Aerie Pharmaceuticals, Inc., Deerfield Private Design Fund III, L.P., Deerfield Partners, L.P. and Deerfield... (Filed With SEC on July 23, 2018)
- Exchange and Termination Agreement, dated as of July 23, 2018, by and among Aerie Pharmaceuticals, Inc., Deerfield Private Design Fund III, L.P., Deerfield Partners, L.P. and... (Filed With SEC on July 23, 2018)
- Underwriting Agreement, dated January 23, 2018, by and between Aerie Pharmaceuticals, Inc. and Cantor Fitzgerald & Co., as representative of the several underwriters named in... (Filed With SEC on January 26, 2018)
- AERIE PHARMACEUTICALS, INC. 1,395,349 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 1, 2017)
- AERIE PHARMACEUTICALS, INC. Up to $50,000,000 of Shares ofCommon Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on May 25, 2017)
- AERIE PHARMACEUTICALS, INC. INDUCEMENT AWARD PLAN RESTRICTED STOCK AGREEMENT (Filed With SEC on March 9, 2017)
- AERIE PHARMACEUTICALS, INC. INDUCEMENT AWARD PLAN FORM OF NONQUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on March 9, 2017)
- FIRST AMENDMENT TO NOTE PURCHASE AGREEMENT (Filed With SEC on March 9, 2017)
- AERIE PHARMACEUTICALS, INC. 2,542,373 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on September 21, 2016)
- AERIE PHARMACEUTICALS, INC. Up to $50,000,000 of Shares ofCommon Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on September 15, 2016)
- AERIE PHARMACEUTICALS, INC. Up to $50,000,000 of Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on November 6, 2015)
- AERIE PHARMACEUTICALS, INC. Up to $50,000,000 of Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on November 6, 2015)
- SECURITY AGREEMENT among AERIEPHARMACEUTICALS, INC. and DEERFIELD PARTNERS, L.P., DEERFIELD INTERNATIONAL MASTER FUND, L.P., DEERFIELD PRIVATE DESIGN FUND III, L.P., DEERFIELD... (Filed With SEC on November 12, 2014)
- PORTIONS OF THIS EXHIBIT DENOTED WITH THREE ASTERISKS (***) HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. NOTE PURCHASE AGREEMENT (Filed With SEC on November 12, 2014)
- Shares Aerie Pharmaceuticals, Inc. Common Stock ($0.001 Par Value) FORM OF EQUITYUNDERWRITING AGREEMENT (Filed With SEC on October 15, 2013)
- FIFTH AMENDMENT OF THE AERIE PHARMACEUTICALS, INC. 2005 STOCK OPTION PLAN (Filed With SEC on October 3, 2013)
- FOURTH AMENDMENT OF THE AERIE PHARMACEUTICALS, INC. 2005 STOCK OPTION PLAN (Filed With SEC on October 3, 2013)
- THIRD AMENDMENT OF THE AERIE PHARMACEUTICALS, INC. 2005 STOCK OPTION PLAN (Filed With SEC on October 3, 2013)
- SECOND AMENDMENT OF THE AERIE PHARMACEUTICALS, INC. 2005 STOCK OPTION PLAN (Filed With SEC on October 3, 2013)
- FIRST AMENDMENT OF AERIE PHARMACEUTICALS, INC. 2005 STOCK OPTION PLAN (Filed With SEC on October 3, 2013)
- AERIE PHARMACEUTICALS, INC. 2005 STOCK OPTION PLAN (Filed With SEC on October 3, 2013)
- FORM OF AERIEPHARMACEUTICALS, INC. EMPLOYEE STOCK PURCHASE PLAN ARTICLE I INTRODUCTION (Filed With SEC on October 3, 2013)
- FIRST AMENDMENT TO AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on October 3, 2013)
- AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on October 3, 2013)
